Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.

2.

Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

3.

How access to specialized cancer centers affects glioblastoma outcomes

4.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

5.

Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot